Literature DB >> 4966834

In vivo-produced anthrax toxin.

D C Fish, R E Lincoln.   

Abstract

Specific anthrax antigens were demonstrated in the blood of animals dying from anthrax. These antigens, which appear in the blood at the time when organisms are first detected and whose concentration continues to increase as the number of organisms increases, do not elicit a strong antibody response. The in vivo-produced toxin differs from the in vitro in killing more rapidly and being more difficult to detect. The in vivo toxin exists as an aggregate whose biological and serological activity depends upon its particular composition or configuration, or both.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4966834      PMCID: PMC252110          DOI: 10.1128/jb.95.3.919-924.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

1.  ALTERATIONS IN THE BIOLOGICAL ACTIVITY OF PROTECTIVE ANTIGEN OF BACILLUS ANTHRACIS TOXIN.

Authors:  D M MOLNAR; R A ALTENBERN
Journal:  Proc Soc Exp Biol Med       Date:  1963-11

2.  STUDIES ON ANTHRAX INFECTIONS IN IMMUNIZED GUINEA PIGS.

Authors:  M K WARD; V G MCGANN; A L HOGGE; M L HUFF; R G KANODE; E O ROBERTS
Journal:  J Infect Dis       Date:  1965-02       Impact factor: 5.226

3.  Surgical procedure for cannulation of theoracic and right lymphatic ducts of rehusus monkeys for survival experimentation.

Authors:  D R HODGES; M A RHIAN
Journal:  Exp Med Surg       Date:  1962

4.  Purification of factors I and II of the anthrax toxin produced in vivo.

Authors:  J L STANLEY; K SARGEANT; H SMITH
Journal:  J Gen Microbiol       Date:  1960-02

5.  A method for assaying anthrax immunising antigen and antibody.

Authors:  F C BELTON; D W HENDERSON
Journal:  Br J Exp Pathol       Date:  1956-04

6.  The chemical basis of the virulence of Bacillus anthracis. VI. An extracellular immunising aggressin isolated from exudates of infected guinea-pigs.

Authors:  H SMITH; R C GALLOP
Journal:  Br J Exp Pathol       Date:  1956-04

7.  Immunologic studies of anthrax. IV. Evaluation of the immunogenicity of three components of anthrax toxin.

Authors:  B G Mahlandt; F Klein; R E Lincoln; B W Haines; W I Jones; R H Friedman
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

8.  Pathophysiology of anthrax.

Authors:  F Klein; J S Walker; D F Fitzpatrick; R E Lincoln; B G Mahlandt; W I Jones; J P Dobbs; K J Hendrix
Journal:  J Infect Dis       Date:  1966-04       Impact factor: 5.226

9.  The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by B. Anthracis in vivo.

Authors:  H SMITH; J KEPPIE; J L STANLEY
Journal:  Br J Exp Pathol       Date:  1955-10

10.  QUANTITATIVE ASSAY FOR CRUDE ANTHRAX TOXINS.

Authors:  B W HAINES; F KLEIN; R E LINCOLN
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

View more
  15 in total

1.  Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma.

Authors:  Alexander F Kintzer; Harry J Sterling; Iok I Tang; Ali Abdul-Gader; Andrew J Miles; B A Wallace; Evan R Williams; Bryan A Krantz
Journal:  J Mol Biol       Date:  2010-04-28       Impact factor: 5.469

Review 2.  Antitoxin Treatment of Inhalation Anthrax: A Systematic Review.

Authors:  Eileen Huang; Satish K Pillai; William A Bower; Katherine A Hendricks; Julie T Guarnizo; Jamechia D Hoyle; Susan E Gorman; Anne E Boyer; Conrad P Quinn; Dana Meaney-Delman
Journal:  Health Secur       Date:  2015 Nov-Dec

3.  Protective antigen as a correlative marker for anthrax in animal models.

Authors:  David Kobiler; Shay Weiss; Haim Levy; Morly Fisher; Adva Mechaly; Avi Pass; Zeev Altboum
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax.

Authors:  Karen E Brenneman; Mehmet Doganay; Arya Akmal; Stanley Goldman; Darrell R Galloway; Alfred J Mateczun; Alan S Cross; Leslie W Baillie
Journal:  FEMS Immunol Med Microbiol       Date:  2011-04-15

5.  Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.

Authors:  J W Ezzell; B E Ivins; S H Leppla
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

6.  Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax.

Authors:  Cynthia A Rossi; Melanie Ulrich; Sarah Norris; Douglas S Reed; Louise M Pitt; Elizabeth K Leffel
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

7.  The protective antigen component of anthrax toxin forms functional octameric complexes.

Authors:  Alexander F Kintzer; Katie L Thoren; Harry J Sterling; Ken C Dong; Geoffrey K Feld; Iok I Tang; Teri T Zhang; Evan R Williams; James M Berger; Bryan A Krantz
Journal:  J Mol Biol       Date:  2009-07-20       Impact factor: 5.469

8.  Purification and properties of in vitro-produced anthrax toxin components.

Authors:  D C Fish; B G Mahlandt; J P Dobbs; R E Lincoln
Journal:  J Bacteriol       Date:  1968-03       Impact factor: 3.490

9.  Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding.

Authors:  Zhaochun Chen; Mahtab Moayeri; Huaying Zhao; Devorah Crown; Stephen H Leppla; Robert H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

10.  Rapid homogenous time-resolved fluorescence (HTRF) immunoassay for anthrax detection.

Authors:  Noam Cohen; Adva Mechaly; Ohad Mazor; Morly Fisher; Eran Zahavy
Journal:  J Fluoresc       Date:  2014-02-12       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.